Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified is the 368th most traded HS4 level product.

In 2024, the top partners where Estonia exported Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified to were Lithuania (€3.11M), Russian Federation (€1.87M), Latvia (€762k), Germany (€592k), and United Kingdom (€130k). During the same period, Estonia imported Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified from Germany (€30.3M), Lithuania (€25.4M), Switzerland (€15.7M), Austria (€8.55M), and Poland (€4.09M).

Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera and other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excl. yeasts) and similar products; cell cultures, whether or not modified is a 4 digit product (HS4 ID 3002).